IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc. (IDXX)
Compare

IDXX Cash Flow Statement

Operating, investing, and financing cash flow analysis

IDXX Quarterly Cash Flow Statement (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
Cash from Operations (CFO)
1.206B266.248M352.022M402.340M185.743M237.962M262.025M220.079M248.312M
1.095B278.446M248.188M274.610M293.989M242.677M216.149M232.841M203.298M
Depreciation & Amortization
111.120M0.0038.721M36.627M35.772M34.063M33.706M34.133M32.193M
-14.615M0.000.00-44.084M29.469M14.615M14.258M15.918M15.719M
Change in Accounts Receivable
2.499B603.544M628.206M638.834M628.471M590.396M534.326M572.666M592.320M
Change in Inventory
Change in Accounts Payable
Change in Working Capital
-12.082M-89.748M16.979M224.543M-163.856M-60.687M-8.735M-57.368M14.281M
Cash from Investing
-126.634M-31.984M-29.434M-31.114M-34.102M-30.026M-39.255M-28.089M-33.305M
0.000.000.000.000.000.000.00306K0.00
Cash from Financing
Debt Repayment
-1.167B-351.036M-237.774M-240.195M-338.105M-400.890M-245.992M-220.757M-215.521M
0.000.000.000.000.000.000.000.000.00
1.080B234.264M322.588M371.226M151.641M207.936M222.770M191.990M215.007M
Net Change in Cash
36.558M20.458M-28.096M43.572M624K-124.296M-20.370M-92.954M4.157M

IDXX Annual Cash Flow Statement (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Cash from Operations (CFO)
1.178B929.001M906.510M542.984M755.546M648.063M459.158M400.084M
1.059B887.867M845.042M679.089M744.845M581.776M427.720M377.031M
Depreciation & Amortization
106.462M129.936M114.908M111.900M104.596M95.998M88.011M83.178M
0.0060.295M59.739M49.770M37.755M30.951M39.278M25.157M
Change in Accounts Receivable
628.206M534.326M512.556M442.473M406.120M355.266M286.971M248.855M
Change in Inventory
Change in Accounts Payable
Change in Working Capital
-227.514M-133.238M-72.429M-273.530M-137.523M-31.761M-104.969M-91.640M
Cash from Investing
-124.676M-130.922M-133.631M-148.838M-119.549M-107.626M-155.224M-122.936M
0.00-77.698M0.00-46.512M-173.418M-1.750M-50.304M-22.500M
Cash from Financing
Debt Repayment
-1.217B-837.034M-71.920M-819.711M-746.777M-182.815M-301.658M-369.319M
0.000.000.000.000.000.000.000.00
1.053B798.079M772.879M394.146M635.997M540.437M303.934M277.148M
Net Change in Cash
-108.196M-165.666M341.386M-31.908M-239.474M293.602M-33.468M-63.881M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Westbrook, ME
11,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky